Skin Safety and Clinical Evaluation of 0.1% Hydrocortisone 17-butyrate 21-propionate (HBP)

Ritsuko Hayakawa, Kayoko Matsunaga

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We studied about the skin safety and clinical evaluation of 0.1% Hydrocortisone 17-butyrate 21 -propionate (HBP). 40 patients with skin diseases were patch tested with HBP ointment, cream, ointment base and cream base. And skin irritation indices were calicurated as 2. 5, 1. 25, 1. 75 and 1. 84 respectively. 2 patients were reacted to methyl paraben formulated in the crem base as a preservative. 41 patients with skin diseases were treated with HBP ointment. The patients applied HBP ointment simply to their lesions three times a day. 14 cases out of the 41 patients (34. 2%) were completely cured and 19 cases (46. were well improved within three weeks. Side effect was shown in one case.

Original languageEnglish
Pages (from-to)130-138
Number of pages9
Journalskin research
Volume26
Issue number1
DOIs
Publication statusPublished - 01-01-1984
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Dermatology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Skin Safety and Clinical Evaluation of 0.1% Hydrocortisone 17-butyrate 21-propionate (HBP)'. Together they form a unique fingerprint.

  • Cite this